Journal of Reproductive Immunology
Volume 83, Issue 1 , Pages 196-200 , December 2009

Mucosal immunology of the genital and gastrointestinal tracts and HIV-1 infection

  • Jiri Mestecky

      Affiliations

    • Department of Microbiology, University of Alabama at Birmingham, USA
    • Department of Medicine, University of Alabama at Birmingham, USA
    • Department of Microbiology and Immunology, Charles University, Prague, Czech Republic
    • Corresponding Author InformationCorresponding author at: Department of Microbiology, University of Alabama at Birmingham, Box 1, 845 19th Street South, Birmingham, AL 35294, USA. Tel.: +1 205 934 2225; fax: +1 205 934 3894.
    • ,
  • Zina Moldoveanu

      Affiliations

    • Department of Microbiology, University of Alabama at Birmingham, USA
    • ,
  • Phillip D. Smith

      Affiliations

    • Department of Microbiology, University of Alabama at Birmingham, USA
    • Department of Medicine, University of Alabama at Birmingham, USA
    • Birmingham VA Medical Center, USA
    • ,
  • Zdenek Hel

      Affiliations

    • Department of Microbiology, University of Alabama at Birmingham, USA
    • Department of Pathology, University of Alabama at Birmingham, USA
    • ,
  • Rashada C. Alexander

      Affiliations

    • Department of Microbiology, University of Alabama at Birmingham, USA

Received 6 February 2009 ,Revised 16 April 2009 ,Accepted 6 July 2009.

References 

  1. Alexander R, Mestecky J. Neutralizing antibodies in mucosal secretions: IgG or IgA?. Curr. HIV Res. 2007;5:588–593
  2. Baba TW, Liska V, Hofmann-Lehmann R, Vlasak J, Xu W, Ayehunie S, et al. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat. Med. 2000;6:200–206
  3. Baeten JM, Lavreys L, Sagar M, Kreiss JK, Richardson BA, Chohan B, et al. Effect of contraceptive methods on natural history of HIV: studies from the Mombasa cohort. J. Acquir. Immune Defic. Syndr. 2005;38(Suppl. 1):S18–S21
  4. Barnett SW, Srivastava IK, Kan E, Zhou F, Goodsell A, Cristillo AD, et al. Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope. AIDS. 2008;22:339–348
  5. Belec L, Dupre T, Prazuck T, Tevi-Benissan C, Kanga JM, Pathey O, et al. Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection. J. Infect. Dis. 1995;172:691–697
  6. Boyaka PN, McGhee JR, Czerkinsky C, Mestecky J. Mucosal vaccines: an overview. In:  Mestecky J editors. Mucosal Immunology. Third ed.. Amsterdam: Elsevier/Academic Press; 2005;p. 855–873
  7. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 2006;12:1365–1371
  8. Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, Beilman GJ, et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 2004;200:749–759
  9. Broliden K, Haase AT, Ahuja SK, Shearer GM, Andersson J. Introduction: back to basics: mucosal immunity and novel HIV vaccine concepts. J. Intern. Med. 2009;265:5–17
  10. Broliden K, Hinkula J, Devito C, Kiama P, Kimani J, Trabbatoni D, et al. Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers. Immunol. Lett. 2001;79:29–36
  11. Canani RB, Cirillo P, Mallardo G, Buccigrossi V, Secondo A, Annunziato L, et al. Effects of HIV-1 Tat protein on ion secretion and on cell proliferation in human intestinal epithelial cells. Gastroenterology. 2003;124:368–376
  12. Devito C, Hinkula J, Kaul R, Kimani J, Kiama P, Lopalco L, et al. Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects. J. Acquir. Immune Defic. Syndr. 2002;30:413–420
  13. Dorrell L, Hessell AJ, Wang M, Whittle H, Sabally S, Rowland-Jones S, et al. Absence of specific mucosal antibody responses in HIV-exposed uninfected sex workers from the Gambia. AIDS. 2000;14:1117–1122
  14. Hel Z, McGhee JR, Mestecky J. HIV infection: first battle decides the war. Trends Immunol. 2006;27:274–281
  15. Hel, Z., Stringer, E., Mestecky, J., in press. Sex steroid hormones, hormonal contraception, and the immunobiology of HIV-1 infection. Endocr. Rev.
  16. Hirbod T, Broliden K. Mucosal immune responses in the genital tract of HIV-1-exposed uninfected women. J. Intern. Med. 2007;262:44–58
  17. Israel ZR, Marx PA. Nonclassical mucosal antibodies predominate in genital secretions of HIV-1 infected chimpanzees. J. Med. Primatol. 1995;24:53–60
  18. Jameson B, Baribaud F, Pohlmann S, Ghavimi D, Mortari F, Doms RW, et al. Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques. J. Virol. 2002;76:1866–1875
  19. Kaul R, Plummer F, Clerici M, Bomsel M, Lopalco L, Broliden K. Mucosal IgA in exposed, uninfected subjects: evidence for a role in protection against HIV infection. AIDS. 2001;15:431–432
  20. Lehner T, Hoelscher M, Clerici M, Gotch F, Pedneault L, Tartaglia J, et al. European Union and EDCTP strategy in the global context: recommendations for preventive HIV/AIDS vaccines research. Vaccine. 2005;23:5551–5556
  21. Marx PA, Spira AI, Gettie A, Dailey PJ, Veazey RS, Lackner AA, et al. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat. Med. 1996;2:1084–1089
  22. Mascola JR, Stiegler G, VanCott TC, Katinger H, Carpenter CB, Hanson CE, et al. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat. Med. 2000;6:207–210
  23. Matoba N, Magerus A, Geyer BC, Zhang Y, Muralidharan M, Alfsen A, et al. A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs. Proc. Natl. Acad. Sci. U.S.A. 2004;101:13584–13589
  24. Mehandru S, Poles MA, Tenner-Racz K, Manuelli V, Jean-Pierre P, Lopez P, et al. Mechanisms of gastrointestinal CD4+ T-cell depletion during acute and early human immunodeficiency virus type 1 infection. J. Virol. 2007;81:599–612
  25. Mestecky J. Humoral immune responses to the human immunodeficiency virus type-1 (HIV-1) in the genital tract compared to other mucosal sites. J. Reprod. Immunol. 2007;73:86–97
  26. Mestecky J, Jackson S, Moldoveanu Z, Nesbit LR, Kulhavy R, Prince SJ, et al. Paucity of antigen-specific IgA responses in sera and external secretions of HIV-type 1-infected individuals. AIDS Res. Hum. Retroviruses. 2004;20:972–988
  27. Mestecky J, Moldoveanu Z, Russell MW. Immunologic uniqueness of the genital tract: challenge for vaccine development. Am. J. Reprod. Immunol. 2005;53:208–214
  28. Miyazawa M, Lopalco L, Mazzotta F, Lo Caputo S, Veas F, Clerici M. The ‘immunologic advantage’ of HIV-exposed seronegative individuals. AIDS. 2009;23:161–175
  29. Moldoveanu Z, Huang WQ, Kulhavy R, Pate MS, Mestecky J. Human male genital tract secretions: both mucosal and systemic immune compartments contribute to the humoral immunity. J. Immunol. 2005;175:4127–4136
  30. Nag P, Kim J, Sapiega V, Landay AL, Bremer JW, Mestecky J, et al. Women with cervicovaginal antibody-dependent cell-mediated cytotoxicity have lower genital HIV-1 RNA loads. J. Infect. Dis. 2004;190:1970–1978
  31. Pope M, Haase AT. Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Nat. Med. 2003;9:847–852
  32. Raux M, Finkielsztejn L, Salmon-Ceron D, Bouchez H, Excler JL, Dulioust E, et al. Comparison of the distribution of IgG and IgA antibodies in serum and various mucosal fluids of HIV type 1-infected subjects. AIDS Res. Hum. Retroviruses. 1999;15:1365–1376
  33. Schafer F, Kewenig S, Stolte N, Stahl-Hennig C, Stallmach A, Kaup FJ, et al. Lack of simian immunodeficiency virus (SIV) specific IgA response in the intestine of SIV infected rhesus macaques. Gut. 2002;50:608–614
  34. Shacklett BL, Critchfield JW, Ferre AL, Hayes TL. Mucosal T-cell responses to HIV: responding at the front lines. J. Intern. Med. 2009;265:58–66
  35. Shen, R., Richter, H. E., Clements, R. H., Novak, L., Huff, K., Bimczok, D., Sankaran-Walters, S., Dandekar, S., Clapham, P. R., Smythies, L. E., Smith, P. D., in press. Macrophages in vaginal but not intestinal mucosa are monocyte-like and permissive to HIV-1. J. Virol.
  36. Simon V, Ho DD, Abdool Karim Q. HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet. 2006;368:489–504
  37. Skurnick JH, Palumbo P, DeVico A, Shacklett BL, Valentine FT, Merges M, et al. Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure. J. Infect. Dis. 2002;185:428–438
  38. Stringer E, Antonsen E. Hormonal contraception and HIV disease progression. Clin. Infect. Dis. 2008;47:945–951
  39. Stringer EM, Kaseba C, Levy J, Sinkala M, Goldenberg RL, Chi BH, et al. A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. Am. J. Obstet. Gynecol. 2007;197(144):e1–e8
  40. Veazey RS, Marx PA, Lackner AA. Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. Nat. Med. 2003;9:343–346
  41. Wright PF, Kozlowski PA, Rybczyk GK, Goepfert P, Staats HF, VanCott TC, et al. Detection of mucosal antibodies in HIV type 1-infected individuals. AIDS Res. Hum. Retroviruses. 2002;18:1291–1300

PII: S0165-0378(09)00442-2

doi: 10.1016/j.jri.2009.07.005

Journal of Reproductive Immunology
Volume 83, Issue 1 , Pages 196-200 , December 2009

Article Tools